Oncol Res Treat. 2019;42(3):123-127. doi: 10.1159/000495218. Epub 2019 Feb 23.
Mixed adenoneuroendocrine carcinomas (MANECs) are rare malignancies with both neuroendocrine and non-neuroendocrine components. To date, the prognosis of gastroenteropancreatic MANECs remains dismal, and treatment options are mainly based on guidelines for the treatment of pure neuroendocrine carcinomas or small cell lung cancer. Established first-line therapy in the metastatic situation is cisplatin and etoposide. Platinum derivatives are known to cause a variety of side effects also involving the visual system. Severe orbital and optic nerve toxicities have been described mainly after intracarotid infusion of cisplatin.
Herein we report a rare case of a 60-year-old male patient suffering from MANEC of the gastroesophageal junction with HER2/neu overexpression who developed severe orbital and ocular neurotoxicity (grade 3 according to CTCAE v4.03) after intravenous cisplatin.
We discuss diagnostic approaches and differential diagnoses in this clinical situation. Before starting treatment with intravenous and topical steroids, it is crucial to rule out meningeal and cerebral spread as well as paraneoplastic and endocrine syndromes.
混合性腺神经内分泌癌(MANEC)是一种罕见的恶性肿瘤,同时具有神经内分泌和非神经内分泌成分。迄今为止,胃肠胰神经内分泌癌的预后仍然很差,治疗方案主要基于治疗纯神经内分泌癌或小细胞肺癌的指南。转移性疾病的既定一线治疗是顺铂和依托泊苷。已知铂衍生物会引起多种涉及视觉系统的副作用。顺铂颈动脉内输注后主要描述了严重的眼眶和视神经毒性。
本文报告了一例罕见的胃食管交界处 MANEC 病例,该患者 HER2/neu 过表达,静脉注射顺铂后发生严重眼眶和眼神经毒性(根据 CTCAE v4.03 分级 3 级)。
我们在这种临床情况下讨论了诊断方法和鉴别诊断。在开始静脉和局部类固醇治疗之前,必须排除脑膜和脑转移以及副肿瘤和内分泌综合征。